Literature DB >> 7833475

Calin from Hirudo medicinalis, an inhibitor of platelet adhesion to collagen, prevents platelet-rich thrombosis in hamsters.

H Deckmyn1, J M Stassen, I Vreys, E Van Houtte, R T Sawyer, J Vermylen.   

Abstract

Interaction between exposed collagen and platelets and/or von Willebrand factor is believed to be one of the initiating events for thrombus formation at sites of damaged endothelium. Interference with this mechanism may provide an anti-thrombotic potential. Calin, a product from the saliva of the leech Hirudo medicinalis, was tested in vitro and for its in vivo activity in a thrombosis model in hamsters. Calin specifically and dose dependently (IC50:6.5 to 13 micrograms/mL) inhibited human platelet aggregation induced by collagen. In addition, specific platelet adhesion onto microtiter wells coated with collagen and detected with a monoclonal antiglycoprotein IIb/IIIa antibody-conjugated with horseradish peroxidase, could be completely prevented with Calin (IC50:22 micrograms/mL). A dose-response curve was constructed in groups of six hamsters in whom a standardized trauma was induced on the femoral vein. Thrombus formation was followed continuously using video recording and processing of the image obtained upon transillumination of the vessel. Intravenous Calin dose-dependently inhibited platelet-rich thrombus formation in this model with an ED50 of 0.07 mg/kg and complete inhibition with 0.2 mg/kg. No effects were seen on coagulation tests or bleeding times, whereas ex vivo aggregation induced by collagen was inhibited dose dependently. Local application of leech saliva, Calin, hirudin, or the combination of the latter two into the bleeding time wound of hamsters resulted in a mild prolongation of the bleeding time (twofold to threefold). A similar experiment in baboons did not cause any prolongation of the bleeding time. This is in sharp contrast with the long-lasting bleeding after a leech bite itself in both species. Calin from the leech Hirudo medicinalis is able, by binding to collagen, to effectively interfere with platelet-collagen interaction, which results in an antithrombotic effect observed in a platelet-rich thrombosis model in hamsters.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7833475

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

Review 1.  Small bite, large impact-saliva and salivary molecules in the medicinal leech, Hirudo medicinalis.

Authors:  Jan-Peter Hildebrandt; Sarah Lemke
Journal:  Naturwissenschaften       Date:  2011-11-09

2.  Prolonged bleeding due to a medicinal leech bite: another treatment method, primary suture.

Authors:  Suat Zengin; Pinar Yarbil; Hasan Kilic; Behçet Al
Journal:  BMJ Case Rep       Date:  2012-07-13

3.  Leech bite: a rare gynecologic emergency.

Authors:  P K Saha; S Roy; D Bhattacharya; P Mukherjee; T Naskar; A Bhuiya
Journal:  MedGenMed       Date:  2005-12-20

4.  Diverse molecular data demonstrate that commercially available medicinal leeches are not Hirudo medicinalis.

Authors:  Mark E Siddall; Peter Trontelj; Serge Y Utevsky; Mary Nkamany; Kenneth S Macdonald
Journal:  Proc Biol Sci       Date:  2007-06-22       Impact factor: 5.349

Review 5.  Platelet aggregation inhibitors from hematophagous animals.

Authors:  Ivo M B Francischetti
Journal:  Toxicon       Date:  2009-12-24       Impact factor: 3.033

6.  Intraperitoneal leech: A rare complication of leech bite.

Authors:  Manoj Saha; Sedengulie Nagi
Journal:  J Indian Assoc Pediatr Surg       Date:  2011-10

Review 7.  European Medicinal Leeches-New Roles in Modern Medicine.

Authors:  Sarah Lemke; Andreas Vilcinskas
Journal:  Biomedicines       Date:  2020-04-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.